AkzoNobel inaugurates chlorine membrane electrolysis plant in Germany following €140M conversion and expansion project; plant produces building blocks for manufacture of products ranging from pharmaceuticals and tooth paste to door and window frames

Elyse Blye

Elyse Blye

AMSTERDAM , May 6, 2014 (press release) – AkzoNobel today inaugurated its new, highly efficient chlorine membrane electrolysis plant in the Rhein-Main area, Germany. The Frankfurt-based, state-of-the-art plant is the result of a major conversion and expansion project begun in 2011 and involving a €140 million investment by the company. Capacity has been increased by 50 percent whilst at the same time reducing the plant’s overall ecological footprint by some 20 percent.

"This investment in our Specialty Chemicals business highlights the steps we are taking to strengthen our market positions and further improve our performance as a company," said AkzoNobel CEO Ton Büchner. "We are constantly looking for new and innovative ways to improve our operational efficiency, drive our sustainability agenda and improve our service to customers."

Added Werner Fuhrmann, the company’s Executive Committee member responsible for Specialty Chemicals: "This plant produces building blocks for the manufacture of products we all use on a daily basis ranging from pharmaceuticals and tooth paste to door and window frames. By radically improving our efficiency and increasing our use of renewable energy, we can take significant steps in making these everyday essentials even more sustainable."

To mark the inauguration, a special event is being held today for employees, customers and other business partners. It will be attended by both Ton Büchner and Werner Fuhrmann, as well as Tarek Al-Wazir, Minister for Economy, Energy, Transport and Regional Development for the federal state of Hessen who stated: "The new chlorine production facility of AkzoNobel Industrial Chemicals is a good example that economy and ecology are compatible; and it is a strong signal for the strengthening of the chemical cluster Hessen."

The facility has been converted to the latest generation membrane technology. Radical efficiency improvements will reduce energy consumption by 30 percent per ton of product. Boosting chlorine production capacity up to 250 kilotons per year will also reinforce the company’s leading positions in Europe's chlor-alkali markets.

Work at Frankfurt started in 2011, with commercial production from the new plant expected to come on stream in the next few weeks. The site is one of three chlorine plants operated by AkzoNobel in Germany, the other two being located in Bitterfeld and Ibbenbüren.

Products from the salt-chlorine chain, including chlorine, caustic lye, and derivatives including MCA and chloromethanes, are essential basic chemicals and are used in countless everyday products and processes, ranging from water disinfection to clothing, amongst other things in the manufacture of epoxies, polyurethanes, polycarbonates, PVC and titanium dioxide. They are also used in the manufacture of more than two thirds of all pharmaceuticals.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

Share:

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.